Your session is about to expire
← Back to Search
Imaging Device
Optical coherence tomography angiography for Diabetic Retinopathy
N/A
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights
Study Summary
This trial will compare retinas of patients with diabetes to healthy controls, in order to evaluate micro-vascular changes in diabetes.
Eligible Conditions
- Diabetic Retinopathy
- Diabetes
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Perfusion density
Secondary outcome measures
Areas of different perfusion density
Change in perfusion density in patients with moderate or severe non proliferative diabetic retinopathy (DR) or low risk proliferative DR over the follow up of one year
Foveal avascular zone (FAZ)
+2 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: OCTAExperimental Treatment1 Intervention
Patients with diabetes and healthy controls will be imaged with optical coherence tomography (OCT) angiography, Spectral domain OCT and ultra wide-field imaging.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Optical coherence tomography angiography
2017
N/A
~420
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,422 Previous Clinical Trials
2,468,085 Total Patients Enrolled
4 Trials studying Diabetic Retinopathy
38 Patients Enrolled for Diabetic Retinopathy
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger